专利检索 ap:("JANSSEN BIOTECH, INC.") AND inv:"Sheri MOORES" 第 1 页

1.

发明公开
COMBINATION THERAPIES WITH BISPECIFIC ANTI-EGFR/C-MET ANTIBODIES AND THIRD GENERATION EGFR TYROSINE KINASE INHIBITORS 审中-公开

公开(公告)号：US20240199748A1

公开(公告)日：2024-06-20

申请号：US18510412

申请日：2023-11-15

申请人： JANSSEN BIOTECH, INC.

发明人： Sylvie LAQUERRE , Matthew LORENZI , Sheri MOORES

IPC分类号： C07K16/28 , A61K31/5377 , A61K39/00 , A61K39/395 , A61P35/00

CPC分类号： C07K16/2863 , A61K31/5377 , A61K39/39558 , A61P35/00 , A61K2039/505 , C07K2317/31 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/565

摘要： The present invention relates to combination therapies with bispecific anti-EGFR/c-Met antibodies and 3rd generation EGFR tyrosine kinase inhibitors.

2.

发明申请
COMBINATION THERAPIES AND PATIENT STRATIFICATION WITH BISPECIFIC ANTI-EGFR/C-MET ANTIBODIES 有权

公开(公告)号：US20230130600A1

公开(公告)日：2023-04-27

申请号：US17817295

申请日：2022-08-03

申请人： JANSSEN BIOTECH, INC.

发明人： Sheri MOORES , Smruthi VIJAYARAGHAVAN

IPC分类号： C07K16/28

摘要： The present invention relates to combination therapies and patient stratification with bispecific anti-EGFR/c-Met antibodies.